Phosphorylation state and protein levels measured in BRAF(V600E/D) melanoma cell lines monitored by imaging - Dataset (ID:20219)
Download: Excel (XLSX), Comma-separated (CSV)
Small Molecule | Cell Line | 2nd Drug | Drug Concentration | Conc Unit | Time Point | Time Point Unit | Image | Measured Protein (Alexa Fluor 488) | Measured Protein Value (488) | Measured Protein (Alexa Fluor 568) | Measured Protein Value (568) | Measured Protein (Alexa Fluor 647) | Measured Protein Value (647) | Replicate | Plate Name | Plate Well |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vemurafenib | COLO 858 | 0.3200 | uM | 24 | hr | p27 Kip1 | 964.47 | p-Rb(S807/S811) | 50.08 | p-ERK(T202/Y204) | 25.09 | 1 | Colo858-signal1 | B5 | ||
Vemurafenib | COLO 858 | 2.0000 | uM | 24 | hr | p27 Kip1 | 1027.10 | p-Rb(S807/S811) | 46.02 | p-ERK(T202/Y204) | 14.33 | 2 | Colo858-signal1 | C3 | ||
JNK-IN-8 | COLO 858 | 0.0000 | uM | 24 | hr | p27 Kip1 | 445.15 | p-Rb(S807/S811) | 158.36 | p-ERK(T202/Y204) | 601.12 | 2 | Colo858-signal1 | E11 | ||
JNK-IN-8 | COLO 858 | 0.0205 | uM | 24 | hr | p27 Kip1 | 439.43 | p-Rb(S807/S811) | 169.34 | p-ERK(T202/Y204) | 657.25 | 1 | Colo858-signal1 | D8 | ||
JNK-IN-8 | COLO 858 | 0.8000 | uM | 24 | hr | p27 Kip1 | 488.74 | p-Rb(S807/S811) | 190.14 | p-ERK(T202/Y204) | 694.83 | 1 | Colo858-signal1 | D4 | ||
JNK-IN-8 | COLO 858 | 0.8000 | uM | 24 | hr | p27 Kip1 | 504.81 | p-Rb(S807/S811) | 190.17 | p-ERK(T202/Y204) | 719.29 | 2 | Colo858-signal1 | E4 | ||
Vemurafenib | COLO 858 | 0.1280 | uM | 24 | hr | p27 Kip1 | 849.44 | p-Rb(S807/S811) | 79.57 | p-ERK(T202/Y204) | 75.64 | 1 | Colo858-signal1 | B6 | ||
Vemurafenib | COLO 858 | 0.0033 | uM | 24 | hr | p27 Kip1 | 489.20 | p-Rb(S807/S811) | 160.66 | p-ERK(T202/Y204) | 628.14 | 2 | Colo858-signal1 | C10 | ||
Vemurafenib | COLO 858 | JNK-IN-8 | 2.0000 | uM | 24 | hr | p27 Kip1 | 1676.60 | p-Rb(S807/S811) | 60.57 | p-ERK(T202/Y204) | 20.44 | 2 | Colo858-signal1 | G3 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.0033 | uM | 24 | hr | p27 Kip1 | 421.06 | p-Rb(S807/S811) | 154.67 | p-ERK(T202/Y204) | 537.34 | 2 | Colo858-signal1 | G10 | |
Vemurafenib | COLO 858 | 0.1280 | uM | 24 | hr | p27 Kip1 | 904.25 | p-Rb(S807/S811) | 65.93 | p-ERK(T202/Y204) | 58.28 | 2 | Colo858-signal1 | C6 | ||
JNK-IN-8 | COLO 858 | 0.0033 | uM | 24 | hr | p27 Kip1 | 438.30 | p-Rb(S807/S811) | 160.10 | p-ERK(T202/Y204) | 626.02 | 1 | Colo858-signal1 | D10 | ||
JNK-IN-8 | COLO 858 | 0.0082 | uM | 24 | hr | p27 Kip1 | 438.93 | p-Rb(S807/S811) | 156.13 | p-ERK(T202/Y204) | 620.57 | 2 | Colo858-signal1 | E9 | ||
Vemurafenib | COLO 858 | 0.0205 | uM | 24 | hr | p27 Kip1 | 483.48 | p-Rb(S807/S811) | 154.86 | p-ERK(T202/Y204) | 515.79 | 2 | Colo858-signal1 | C8 | ||
Vemurafenib | COLO 858 | JNK-IN-8 | 0.1280 | uM | 24 | hr | p27 Kip1 | 738.58 | p-Rb(S807/S811) | 81.58 | p-ERK(T202/Y204) | 80.67 | 1 | Colo858-signal1 | F6 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.0512 | uM | 24 | hr | p27 Kip1 | 511.00 | p-Rb(S807/S811) | 125.23 | p-ERK(T202/Y204) | 254.95 | 2 | Colo858-signal1 | G7 | |
Vemurafenib | COLO 858 | 0.8000 | uM | 24 | hr | p27 Kip1 | 1063.20 | p-Rb(S807/S811) | 48.29 | p-ERK(T202/Y204) | 17.48 | 1 | Colo858-signal1 | B4 | ||
JNK-IN-8 | COLO 858 | 0.1280 | uM | 24 | hr | p27 Kip1 | 450.18 | p-Rb(S807/S811) | 173.59 | p-ERK(T202/Y204) | 691.16 | 1 | Colo858-signal1 | D6 | ||
JNK-IN-8 | COLO 858 | 0.0033 | uM | 24 | hr | p27 Kip1 | 442.59 | p-Rb(S807/S811) | 160.97 | p-ERK(T202/Y204) | 615.32 | 2 | Colo858-signal1 | E10 | ||
JNK-IN-8 | COLO 858 | 0.1280 | uM | 24 | hr | p27 Kip1 | 429.89 | p-Rb(S807/S811) | 170.46 | p-ERK(T202/Y204) | 675.31 | 2 | Colo858-signal1 | E6 | ||
JNK-IN-8 | COLO 858 | 0.0512 | uM | 24 | hr | p27 Kip1 | 429.12 | p-Rb(S807/S811) | 167.32 | p-ERK(T202/Y204) | 661.59 | 2 | Colo858-signal1 | E7 | ||
Vemurafenib | COLO 858 | JNK-IN-8 | 0.8000 | uM | 24 | hr | p27 Kip1 | 1176.20 | p-Rb(S807/S811) | 47.97 | p-ERK(T202/Y204) | 25.00 | 1 | Colo858-signal1 | F4 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.0205 | uM | 24 | hr | p27 Kip1 | 462.46 | p-Rb(S807/S811) | 154.40 | p-ERK(T202/Y204) | 499.08 | 1 | Colo858-signal1 | F8 | |
JNK-IN-8 | COLO 858 | 0.0512 | uM | 24 | hr | p27 Kip1 | 430.28 | p-Rb(S807/S811) | 171.77 | p-ERK(T202/Y204) | 673.40 | 1 | Colo858-signal1 | D7 | ||
Vemurafenib | COLO 858 | 0.0512 | uM | 24 | hr | p27 Kip1 | 555.61 | p-Rb(S807/S811) | 125.96 | p-ERK(T202/Y204) | 272.64 | 1 | Colo858-signal1 | B7 |